Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-11-06
2007-11-06
Campell, Bruce R. (Department: 1648)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C424S189100, C424S218100, C435S069100, C435S320100, C536S023100
Reexamination Certificate
active
10693258
ABSTRACT:
The present application provides GB virus C sequences (GBV-C or hepatitis G virus) and methods of using the sequences.
REFERENCES:
patent: 5620896 (1997-04-01), Herrmann et al.
patent: 5766840 (1998-06-01), Kim et al.
patent: 5766916 (1998-06-01), Belyaev et al.
patent: 5824507 (1998-10-01), Kim et al.
patent: 5849532 (1998-12-01), Kim et al.
patent: 5856134 (1999-01-01), Kim et al.
patent: 5859230 (1999-01-01), Kim et al.
patent: 5874563 (1999-02-01), Kim et al.
patent: 5958895 (1999-09-01), Pachuk et al.
patent: 5981172 (1999-11-01), Simons et al.
patent: 6004799 (1999-12-01), Luciw et al.
patent: 6156495 (2000-12-01), Pilot-Matias et al.
patent: 6870043 (2005-03-01), Xiang et al.
patent: 2003/0170870 (2003-09-01), Xiang et al.
Xiang, J. , et al., “Effect of Coinfection with GB Virus C on Survival Among Patients with HIV Infection”,N. Engl. J. Med., vol. 345, No. 10 (Sep. 6, 2001), 707-714.
Xiang, J. , et al., “Full-Length GB Virus C (Hepatitis G Virus) RNA Transcripts Are Infections in Primary CD4-Positive T Cells”,Journal of Virology, vol. 74, No. 19 (Oct. 2000) 9125-9133.
Akiyoshi, et al., “Intraspousal Transmission of GB Virus C/Hepatitis G Virus in an Hepatitis C Virus Hyperendemic Area in Japan,”Am. J. Gastroenterol., 94(6):1627-1631, 1999.
Asada, et al., “Human Herpesvirus 6 Infects Dendritic Cells and Suppresses Human Immunodeficiency Virus Type 1 Replication in Coinfected Cultures,”J. Virol. 73(5):4019-4028, 1999.
Beard, et al., “An Infectious Molecular Clone of a Japanese Genotype 1b Hepatitis C Virus,”Hepatology, 30(1):316-324, 1999.
Birkenmeyer, et al., “Isolation of a GB Virus-Related Genome From a Chimpanzee,”J. Med. Virol., 56:44-51, 1998.
Bukh, et al., “Experimental Infection of Chimpanzees with Hepatitis G Virus and Genetic Analysis of the Virus,”J. Inf. Dis., 177:855-862, 1998.
Bukh, et al., “Toward a Surrogate Model for Hepatitis C Virus: An Infectious Molecular Clone of the GB Virus-B Hepatitis Agent,”Virol., 262:470-478, 1999.
Cohen, et al., “Hepatitis A Virus cDNA and Its RNA Transcripts Are Infectious in Cell Culture,”J. Virol., 61(10):3035-3039, 1987.
Dawson, et al., “Prevalence Studies of GB Virus-C Infection Using Reverse Transcriptase-Polymerase Chain Reaction,”J. Med. Virol., 50:97-103, 1996.
de Martino, et al., “Hepatitis G Virus Infection in Human Immunodeficiency Virus Type 1-Infected Mothers and Their Children,”J. Infect. Dis., 178:862-865, 1998.
Deacon, et al., “Genomic Structures of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients,”Science, 270:988-991, 1995.
Dickens, et al., “GB Virus C, Hepatitis G Virus, or Human Orphan Flavivirus?”Hepatology, 25(5):1285-1286, 1997.
Easterbrook, “Long-term Non-Progression in HIV Infection: Definitions and Epidemiological Issues,”J. Infect,. 38:71-73, 1999.
Elvander, et al., “An Experimental Study of a Concurrent Primary Infection with Bovine Respiratory Syncytial Virus (BRSV) and Bovine Viral Diarrhoea Virus (BVDV) in Calves,”Acta. Vet.Scand,. 39:251-264, 1998.
Emerson, et al., “cDNA Clone of Hepatitis A Virus Encoding a Virulent Virus: Induction of Viral Hepatitis by Direct Nucleic Acid Transfection of Marmosets,”J. Virol., 66(11):6649-6654, 1992.
Feucht, et al., “Distribution of Hepatitis G Viremia and Antibody Response to Recombinant Proteins With Special Regard to Risk Factors in 709 Patients,”Hepatology, 26(2):491-494, 1997.
Fogeda, et al.,. In Vitro Infection of Human Peripheral Blood Mononuclear Cells by GB Virus C/Hepatitis G Virus,J. Virol. 73(5):4052-4061, 1999.
Gale, Jr,. et al., “Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase Regulation,”Mol. Cell.Biol. 18(9):5208-5218, 1998.
Gutierrez, et al., “Seroprevalence of GB Virus C and Persistence of RNA and Antibody,”J. Med. Virol., 53:167-173, 1997.
Hong, et al., “Generation of Transmissible Hepatitis C Virions from a Molecular Clone in Chimpanzees,”Virology, 256:36-44, 1999.
Kolykhalov, et al., “Transmission of Hepatitis C by Intrahepatic Inoculation with Transcribed RNA,”Science, 277:570-574, 1997.
Laskus, et al., “Detection of Hepatitis G Virus Replication Sites by Using Highly Strand-Specific Tth-Based Reverse Transcriptase PCR,”J. Virol., 72(4):3072-3075, 1998.
Leary, et al., “Sequence and Genomic Organization of GBV-C: A Novel Member of the Flaviviridae Associated With Human Non-A-E Hepatitis,”J. Med. Virol., 48:60-67, 1996.
Lefrère, et al., “Carriage of GB Virus C/Hepatitis G Virus RNA Is Associated with a Slower Immunologic, Virologic, and Clinical Progression of Human Immunodeficiency Virus Disease in Coinfected Persons,”J.Infect.Dis., 179:783-789, 1999.
Melvin, et al., “Biophysical characterization of GB virus C from human plasma,”J. Virol. Methods, 71:147-157, 1998.
Nerurkar, et al., “High Prevalence of GB Virus C/Hepatitis G Virus Infection Among Homosexual Men Infected With Human Immunodeficiency Virus Type 1: Evidence for Sexual Transmission,”J. Med. Virol., 56:123-127, 1998.
Okamoto, et al., “The entire nucleotide sequences of two GB virus C/hepatitis G virus isolates of distinct genotypes from Japan,”J. Gen. Virol., 78:737-745. 1997.
Pang et al., “Development of dengue virus replicons expressing HIV-1 gp120 and other heterologous genes: a potential future tool for dual vaccination against dengue virus and HIV,” BMC Microbiology, 1(28):1-9, 2001.
Pessoa, et al., “Quantitation of Hepatitis G and C Viruses in the Liver: Evidence That Hepatitis G Virus Is Not Hepatotropic,”Hepatol., 27(3):877-880, 1998.
Pinto, et al., “Inhibition of Human Immunodeficiency Virus Type 1 Replication prior to Reverse Transcription by Influenza Virus Stimulation,”J. Virol. 74(10):4505-4511, 2000.
Rowland-Jones, “Long-term Non-progression in HIV Infection: Clinico pathological Issues,”J.Infect., 38:67-70, 1999.
Sabin, et al., “Effect of Coinfection With Hepatitis G Virus on HIV Disease Progression in Hemophilic Men,”J.Acquir.Immune Defic.Syndr., 19:546-547, 1998.
Schmidt, et al., “Direct Detection of Hepatitis C Virus (HCV) RNA From Whole Blood, and Comparison With HCV RNA in Plasma and Peripheral Blood Monouclear Cells,”J. Med. Virol., 47:153-160, 1995.
Seipp, et al., “Hepatotropism of GB virus C (GBV-C): GBV-C replication in human hepatocytes and cells of human hepatoma cell lines,”J. Hepatol., 30:570-579, 1999.
Shimizu, “Replication of GB Virus C (Hepatitis G Virus) in Interferon-Resistant Daudi Cells,”J. Virol., 73(10):8411-8414, 1999.
Simons, et al., “Identification of two flavivirus-like genomes in the GB hepatitis agent,”Proc.Natl.Acad.Sci.USA 92:34013405, 1995.
Simons, et al., “Translation Initiation in GB Viruses A and C: Evidence for Internal Ribosome Entry and Implications for Genome Organization,”J. Virol., 70(9):6126-6135, 1996.
Stapleton, et al., “Prospective Comparison of Whole-Blood- and Plasma-Based Hepatitis C Virus RNA Detection Systems: Improved Detection Using Whole Blood as the Source of Viral RNA,”J. Clin. Microbiol., 37(3):484-489, 1999.
Tacke, et al., “Humoral Immune Response to the E2 Protein of Hepatitis G Virus Is Associated With Long-Term Recovery From Infection and Reveals a High Frequency of Hepatitis G Virus Exposure Among Healthy Blood Donors,”Hepatol., 26(6):1626-1633, 1997.
Tanaka, et al., “Acute hepatitis caused by sexual or household transmission of GBV-C,”J. Hepatol., 27:1110-1112, 1997.
Taylor, et al., “Inhibition of the Interferon-Inducible Protein Kinase PKR by HCV E2 Protein,”Science, 285:107-110, 1999.
Thomas, et al., “Association of Antibody to GB
George Sarah
Stapleton Jack T.
Xiang Jinhua
Campell Bruce R.
Fullbright & Jaworski LLP
Horning Michelle
University of Iowa Research Foundation
LandOfFree
GB virus C and methods of treating viral infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with GB virus C and methods of treating viral infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and GB virus C and methods of treating viral infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3852457